PTGX News — Page 2
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2017-05-30 | Current report | SEC filing | Protagonist Therapeutics, Inc filed Form 8-K | Protagonist Therapeutics, Inc filed Form 8-K covering items 1.01. |
| 2017-05-25 | Current report | SEC filing | Protagonist Therapeutics, Inc filed Form 8-K | Protagonist Therapeutics, Inc filed Form 8-K covering items 5.07. |
| 2017-05-23 | Current report | SEC filing | Protagonist Therapeutics, Inc filed Form 8-K | Protagonist Therapeutics, Inc filed Form 8-K covering items 8.01. |
| 2017-05-10 | Current report | SEC filing | Protagonist Therapeutics, Inc filed Form 8-K | Protagonist Therapeutics, Inc filed Form 8-K covering items 2.02,9.01. |
| 2017-03-07 | Current report | SEC filing | Protagonist Therapeutics, Inc filed Form 8-K | Protagonist Therapeutics, Inc filed Form 8-K covering items 2.02,9.01. |
| 2017-02-09 | Current report | SEC filing | Protagonist Therapeutics, Inc filed Form 8-K | Protagonist Therapeutics, Inc filed Form 8-K covering items 5.02. |
| 2016-11-14 | Current report | SEC filing | Protagonist Therapeutics, Inc filed Form 8-K | Protagonist Therapeutics, Inc filed Form 8-K covering items 2.02,9.01. |
| 2016-08-16 | Current report | SEC filing | Protagonist Therapeutics, Inc filed Form 8-K | Protagonist Therapeutics, Inc filed Form 8-K covering items 5.03,9.01. |